MedTrace Logo

Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging

NCT06827678 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-06-05

No results posted yet for this study

Summary

The goal of this observational study is to investigate neuroimage and biomarkers in the Alzheimer's continuum in Chinese population. We aimed to:

* To reveal the progress of AD by multiple neuroimage and biomarkers;
* To reveal the longitudinal change of biomarkers and cognition of AD in Chinese population;
* To investigate the interaction of markers between body and brain;
* To set up new markers by neuroimage.

Conditions

  • Alzheimer Disease
  • Positron Emission Tomography

Interventions

OTHER

No Intervention: Observational Cohort

No intervention

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Fang Xie, PhD · Huashan Hospital

Eligibility

Min Age
45 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2027-07-30
Completion
2027-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06827678 on ClinicalTrials.gov